Patents | Intellepedia

Inventive Step Misjudged? Delhi HC Revives Trident’s Patent Application

Composite image showing a close-up of breathable maroon fabric, a cartoon panel of judges giving thumbs up, and colorful yarn balls representing air-rich yarn innovation in a legal patent context

Delhi HC revives Trident’s patent application, citing flaws in the inventive step analysis of its air-rich yarn invention.

Are Employment Agreements sufficient for establishing Proof Of Right?

Close-up of an employment agreement document on a clipboard with a pen placed on top, surrounded by office supplies on a textured surface.

Delhi High Court rules employment agreements valid as proof of right under Section 7(2), aiding patent filings involving deceased inventors.

You Can’t Park Patent Rights in the E-Ricksha Registration Lane

In the case of M/s Sunhok Wheels Pvt. Ltd. & Ors. vs The State of West Bengal & Ors., the Calcutta High Court addressed whether claims of patent rights can prevent registration of e-rickshaws. The court ruled that vehicle registration authorities must act according to statutory rules, and pending patent claims do not automatically restrain registration.

Is a Smarter Scooter Frame Patentable? Court Orders Rethink on Inventive Step

In the case of TVS Motor Company vs Patent Office, a scooter maker’s patent claim for a simple yet novel frame design was rejected for lacking inventive step. The court disagreed with the reasoning and ordered the Patent Office to re-examine the application using a proper test.

Dr Reddy’s Semaglutide Exports to Continue as Court Denies Interim Relief to Novo Nordisk

Semaglutide injection pen with syringe surrounded by weighing scale, tape measure, dumbbell and fast food, symbolising weight loss and diabetes treatment.

The Delhi High Court refused Novo Nordisk interim relief against Dr Reddy’s, finding that the Semaglutide species patent faces serious validity challenges in light of the earlier genus patent. The Court allowed Dr Reddy’s to continue manufacturing Semaglutide in India solely for export to non-patent jurisdictions, with no domestic sales.

Once the Hearing Is Fixed, the Door Closes on New Evidence in Patent Oppositions

In the case of M/s Hi Tech Chemicals Limited vs Deputy Controller of Patents and Designs & Anr., the Madras High Court examined whether documents labeled as additional evidence could be admitted after the hearing was fixed in a post-grant patent opposition. The Court looked at the patent rules, and held that private documents do not qualify as “publications” under Rule 62(4), and are therefore not admissible after the hearing date was fixed.

Delhi High Court Grants Patent Application Restoration After Agent’s Error

Illustration of a courtroom with wooden benches and judge's bench; inset shows a cartoon man scratching his head with a lightbulb over it, symbolizing a sudden realization or mistake.

Delhi High Court restores Synertec’s patent application, ruling that agent error, not intent, caused the missed Form-18 deadline.

Can Claims Presumptively Inherit the Priority Date of a Provisional Application?

Close-up of a person circling a date on a calendar, symbolizing checking timelines

In Rallis India Limited v. Deputy Controller of Patents and Others, the Madras High Court refused to assume that claims automatically inherit the priority date of a provisional, especially where the crucial EC formulation emerges only in the complete specification. The decision pushes the Patent Office to treat priority and prior art questions as matters for analysis, not default settings.

Section 3(i) Rejection Set Aside: Court Clarifies Scope of Pharmaceutical Patent Claims

Banner image showing a human brain against a blue molecular/network background, with overlaid text: “Section 3(i) Rejection Set Aside: Court Clarifies Scope of Pharmaceutical Patent Claims”.

The Delhi High Court reiterated that a properly drafted pharmaceutical composition claim cannot be dismissed as a “method of treatment” under Section 3(i), and has sent Medilabo’s neurodegenerative drug application back for a full, merits-based examination.

Conduct and Misconduct: A New Disciplinary Framework for Patent Agents under the Draft Patents Rules

A close-up of a hand holding a white card with the words “CODE OF CONDUCT” printed in bold letters.

The draft amendments to the Patents Rules, 2003 seek to bring both conduct and misconduct of patent agents within a clear disciplinary framework. This piece walks through the proposed code, procedures and consequences that may soon shape everyday patent practice.